Trends in international asthma mortality: analysis of data from the WHO Mortality Database from 46 countries (1993–2012)

The Lancet

Volumn 390, Issue 10098, 2017, Pages 935-945

  Ebmeier, Stefan ^a   Thayabaran, Darmiga ^a   Braithwaite, Irene ^a   Bénamara, Clément ^a   Weatherall, Mark ^b   Beasley, Richard ^a  

^a MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^b UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; DATA BASE; FEMALE; HIGH INCOME COUNTRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE INCOME COUNTRY; MORTALITY RATE; MORTALITY RISK; PREVALENCE; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION; CAUSE OF DEATH; FACTUAL DATABASE; GLOBAL HEALTH; MORTALITY; PRESCHOOL CHILD; STATISTICAL ANALYSIS; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; ASTHMA; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; FEMALE; GLOBAL HEALTH; HUMANS; MALE; MORTALITY; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 85027129810     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)31448-4     Document Type: Article

References (41)

1. Beasley, R, Pearce, N, Crane, J, International trends in asthma mortality. The Rising Trends in Asthma. Ciba Foundation Symposium 206, 1997, John Wiley & Sons, Chichester, 140–156.
2. Pearce, N, Beasley, R, Crane, J, Burgess, C, Epidemiology of asthma mortality. Holgate, ST, Busse, WW, (eds.) Asthma and Rhinitis, 2nd edn., 2000, Blackwell Scientific Press, Oxford, 58–69.
3. Speizer, FE, Doll, R, Heaf, P, Observations on recent increase in mortality from asthma. BMJ 1 (1968), 335–339.
4. Jackson, RT, Beaglehole, R, Rea, HH, Sutherland, DC, Mortality from asthma: a new epidemic in New Zealand. BMJ 285 (1982), 771–774.
5. Stolley, PD, Why the United States was spared an epidemic of deaths due to asthma. Am Rev Respir Dis 105 (1972), 883–890.
6. Crane, J, Pearce, N, Flatt, A, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981–83: a case control study. Lancet 1 (1989), 917–922.
7. Pearce, N, Beasley, R, Crane, J, Burgess, C, Jackson, R, End of the New Zealand mortality epidemic. Lancet 345 (1995), 41–44.
8. Beasley, R, Pearce, N, Crane, J, Windom, H, Burgess, C, Asthma mortality and inhaled beta agonist therapy. Aust NZ J Med 21 (1991), 753–763.
9. Beasley, R, Pearce, N, Crane, J, Burgess, C, Beta agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?. J Allergy Clin Immunol 103:suppl (1999), S18–S30.
10. Crane, J, Pearce, N, Burgess, C, Beasley, R, Asthma and the β agonist debate. Thorax 50:suppl 1 (1995), S5–S10.
11. Suissa, S, Ernst, P, Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 107 (2001), 937–944.
12. Neffen, H, Baena-Cagnani, C, Passalacqua, G, Canonica, GW, Rocco, D, Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990–1999). Respir Med 100 (2000), 1431–1435.
13. Goldman, M, Rachmiel, M, Gendler, L, Kats, Y, Decrease in asthma mortality rate in Israel from 1991–1995: is it related to increased use of inhaled corticosteroids?. J Allergy Clin Immunol 105 (2000), 71–74.
14. Lim, DL, Ma, S, Wang, XS, Cutter, J, Chew, SK, Trends in sales of inhaled corticosteroids and asthma outcomes in Singapore. Thorax 61 (2006), 362–365.
15. Kumana, CR, Kou, M, Lauder, IJ, Ip, MSM, Lam, WK, Increasing use of inhaled steroids associated with declining asthma mortality. J Asthma 38 (2001), 161–167.
16. Melissinos, CG, Gourgoulianis, K, Adamidis, SC, Inhaled drug consumption and asthma mortality in Greece. Chest 107 (1995), 1771–1772.
17. AIHW Australian Centre for Asthma Monitoring. Asthma in Australia. AIHW Asthma Series 2. AIHW ACM 6, 2005, AIHW, Canberra.
18. Suissa, S, Ernst, P, Use of anti-inflammatory therapy and asthma mortality in Japan. Eur Respir J 21 (2003), 101–104.
19. Haahtela, T, Tuomisto, LE, Pietinalho, A, et al. A 10 year asthma programme in Finland: major change for the better. Thorax 61 (2006), 663–670.
20. Di Santostefano, RL, Davis, KJ, Yancey, S, Crim, C, Ecologic analysis of asthma-related events and dispensing of inhaled corticosteroid- and salmeterol-containing products. Ann Allergy Asthma Immunol 100 (2008), 558–565.
21. Wijesinghe, M, Perrin, K H, Beasley, R, International trends in asthma mortality rates in the 5–34 year age group: a call for closer surveillance. Chest 135 (2009), 1045–1049.
22. Sears, MR, Rea, HH, de Boer, G, et al. Accuracy of certification of deaths due to asthma: a national study. Am J Epidemiol 124 (1986), 1004–1011.
23. Reid, DW, Hendrick, VJ, Aitken, TC, et al. Age-dependent inaccuracy of asthma death certification in Northern England, 1991–1992. Eur Respir J 12 (1998), 1079–1083.
24. Speizer, FE, Doll, R, A century of asthma deaths in young people. BMJ 3 (1968), 245–246.
25. WHO. Mortality Database. http://apps.who.int/healthinfo/statistics/mortality/causeofdeath_query/, 2015 (accessed Dec 1, 2015).
26. Statistics Canada. http://www.statcan.gc.ca/eng/subjects/health/life_expectancy_and_deaths (accessed Dec 1, 2015).
27. New Zealand Ministry of Health. http://www.health.govt.nz/nz-health-statistics/health-statistics-and-data-sets/mortality-data-and-stats, 2015 (accessed Dec 1, 2015).
28. Centers for Disease Control and Prevention. CDC WONDER. http://wonder.cdc.gov/ucd-icd10.html, 2015 (accessed Dec 1, 2015).
29. So, SY, Ng, MMT, Ip, MSM, Lam, WK, Rising asthma mortality in young males in Hong Kong. Respir Med 84 (1990), 457–461.
30. Ahmad, OB, Boschi-Pinto, C, Lopez, AD, Age standardization of rates: a new WHO standard GPE Discussion Paper Series: 31 EIP/GPE/EBD, 2001, World Health Organization, Geneva.
31. Freund, RJ, Littell, RC, SAS System for Regression, 3rd edn., 2000, SAS Institute, Cary, NC, 150–155.
32. Masoli, M, Fabian, D, Holt, S, Beasley, R, for the Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59 (2004), 469–478.
33. Beasley, R, Clayton, T, Crane, J, et al., for the ISAAC Phase Three Study Group. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from phase three of the ISAAC programme. Lancet 372 (2008), 1039–1048.
34. European Community Respiratory Survey. Eur Respir J 9 (1996), 687–695.
35. Pearce, N, Aït-Khaled, N, Beasley, R, et al., the ISAAC Phase Three Study Group. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 62 (2007), 758–766.
36. Mitchell, EA, Is current treatment increasing asthma mortality and morbidity?. Thorax 44 (1989), 81–84.
37. Abramson, MJ, Bailey, MJ, Couper, FJ, et al. Are asthma medications and management related to deaths from asthma?. Am J Respir Crit Care Med 163 (2001), 12–18.
38. Beasley, R, Crane, J, Reducing asthma mortality with the asthma self-management plan system of care. Am J Respir Crit Care Med 163 (2001), 3–4.
39. Royal College of Physicians. Why asthma still kills. The National Review of Asthma Deaths (NRAD). https://www.rcplondon.ac.uk/projects/outputs/why-asthma-still-kills, 2015 (accessed Dec 1, 2015).
40. Goeman, DP, Abramson, MJ, McCarthy, EA, Zubrinich, CM, Douglass, JA, Asthma mortality in Australia in the 21st century: a case series analysis. BMJ Open, 3, 2013, e002539.
41. Agusti, A, Bel, E, Thomas, M, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J 47 (2016), 359–361.